Source: Critical Care Medicine. Unidade: FM
Assunto: CLÍNICA GERAL
ABNT
JAGTAP, Prakash et al. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine, v. 30, n. 5, p. 1071-1082, 2002Tradução . . Acesso em: 25 mar. 2023.APA
Jagtap, P., Soriano, F. G., Virág, L., Liaudet, L., Mabley, J., Szabó, É., et al. (2002). Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine, 30( 5), 1071-1082. doi:10.1097/00003246-200205000-00019NLM
Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó É, Haskó G, Marton A, Lorigados CB, Gallyas Junior F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine. 2002 ; 30( 5): 1071-1082.[citado 2023 mar. 25 ]Vancouver
Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó É, Haskó G, Marton A, Lorigados CB, Gallyas Junior F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, Southan GJ, Szabó C. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphateribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine. 2002 ; 30( 5): 1071-1082.[citado 2023 mar. 25 ]